Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1529
https://www.valueinhealthjournal.com/article/S1098-3015(13)03434-7/fulltext
Title :
Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis- Results from the Open-Label Extension Study of Rapi ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03434-7&doi=10.1016/j.jval.2013.08.1529
First page :
A570
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1373